Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Achieve Life Sciences Analyst Ratings and Price Targets | NASDAQ:ACHV | Benzinga
Achieve Life Sciences Inc has a consensus price target of $13.67 based on the ratings of 6 analysts. The high is $20 issued by Raymond James on September 27, 2024. The low is $8 issued by Maxim Group on November 16, 2022. The 3 most-recent analyst ratings were released by Rodman & Renshaw, Raymond James, and Oppenheimer on November 14, 2024, September 27, 2024, and August 15, 2024, respectively. With an average price target of $14.33 between Rodman & Renshaw, Raymond James, and Oppenheimer, there's an implied 405.58% upside for Achieve Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Rodman & Renshaw
Raymond James
Oppenheimer
JonesTrading
Lake Street
1calculated from analyst ratings
Analyst Ratings for Achieve Life Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/14/2024 | Buy Now | 323.28% | Rodman & Renshaw | Brandon Folkes43% | → $12 | Initiates | → Buy | Get Alert |
| 09/27/2024 | Buy Now | 605.47% | Raymond James | Gary Nachman59% | → $20 | Initiates | → Strong Buy | Get Alert |
| 08/15/2024 | Buy Now | 288.01% | Oppenheimer | Francois Brisebois44% | $11 → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 05/13/2024 | Buy Now | 288.01% | Oppenheimer | Francois Brisebois44% | $18 → $11 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 605.47% | JonesTrading | Justin Walsh40% | → $20 | Initiates | → Buy | Get Alert |
| 04/01/2024 | Buy Now | 534.92% | Oppenheimer | Francois Brisebois44% | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 03/05/2024 | Buy Now | 288.01% | Lake Street | Thomas Flaten37% | $19 → $11 | Maintains | Buy | Get Alert |
| 12/12/2023 | Buy Now | 534.92% | Oppenheimer | Francois Brisebois44% | $21 → $18 | Maintains | Outperform | Get Alert |
| 05/31/2023 | Buy Now | 570.19% | Lake Street | Thomas Flaten37% | $22 → $19 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 676.01% | Lake Street | Thomas Flaten37% | → $22 | Maintains | Buy | Get Alert |
| 03/17/2023 | Buy Now | 499.65% | Oppenheimer | Francois Brisebois44% | → $17 | Reiterates | → Outperform | Get Alert |
| 11/16/2022 | Buy Now | 182.19% | Maxim Group | Jason McCarthy42% | $21 → $8 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Achieve Life Sciences (ACHV) stock?
The latest price target for Achieve Life Sciences (NASDAQ:ACHV) was reported by Rodman & Renshaw on November 14, 2024. The analyst firm set a price target for $12.00 expecting ACHV to rise to within 12 months (a possible 323.28% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Achieve Life Sciences (ACHV)?
The latest analyst rating for Achieve Life Sciences (NASDAQ:ACHV) was provided by Rodman & Renshaw, and Achieve Life Sciences initiated their buy rating.
When was the last upgrade for Achieve Life Sciences (ACHV)?
There is no last upgrade for Achieve Life Sciences
When was the last downgrade for Achieve Life Sciences (ACHV)?
There is no last downgrade for Achieve Life Sciences.
When is the next analyst rating going to be posted or updated for Achieve Life Sciences (ACHV)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Achieve Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Achieve Life Sciences was filed on November 14, 2024 so you should expect the next rating to be made available sometime around November 14, 2025.
Is the Analyst Rating Achieve Life Sciences (ACHV) correct?
While ratings are subjective and will change, the latest Achieve Life Sciences (ACHV) rating was a initiated with a price target of $0.00 to $12.00. The current price Achieve Life Sciences (ACHV) is trading at is $2.84, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.